https://www.news-medical.net/news/20230615/Phase-3-clinical-trial-shows-favorable-safety-and-immunogenicity-profile-of-single-shot-live-attenuated-chikungunya-vaccine.aspx
0
0
6/15/23 at 1:57pm
Organization
News-Medical.Net
29 words
0
Comments
Researchers performed a double-blinded, phase III randomized trial.
You are the first to view
Create an account
or login to join the discussion